In conclusion, our findings indicate that tumour-derived STAT1 regulates HNSCC tumorigenicity and PD-L1 immune checkpoint signalling, while T-cell-derived STAT1 is necessary for immune activation and anti-tumour immune responses. The gene discussed is STAT1; the disease is head and neck squamous cell carcinoma.